BÁO CÁO Y HỌC: "CURRENT PHARMACOLOGIC OPTIONS FOR PATIENTS WITH ALZHEIMER''''S DISEASE" PPS

and severity of disease. Am J Gastroenterol 2001; 96:2957. 10. Pagano G, Pacini G, Musso G, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association. Hepatology 2002; 35:367. 11. Marchesini G, Brizi M, Morselli-Labate AM, et al. A[r]

available to help decide which population of patients should undergo therapy. The American Association for the Study of Liver Diseases (AASLD) recognizes three categories of patients: those in whom therapy is widely accepted, those in whom therapy should be individualized and, those in whom therapy[r]

References 1. Labenz J, Borsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut. 1994; 35: 19-22. 2. IARC. Infection with Helicobacter pylori. In: IARC monographs on the evaluation of the carcinogenic risks to humans. Lyon, France: International Agency for Rese[r]

as assessed by an HCV RNA assay with a lower limit of detection of 50 IU/ml or less 24 weeks after the end of treatment [18]. Initiation of therapy Only patients with detectable HCV RNA should be considered for pegylated IFN alfa and ribavirin combination therapy [18]. The decision to treat patients[r]

Murray-Lyon IM. Prevalence of hepatitis B, C and D virus markers in Yemeni patients with chronic liver disease. J Med Virol 1993;40:330–333. 35. Frommel D, Tekle-Haimanot R, Berhe N, Aussel L, Verdier M, Preux PM, Denis F. A survey of antibodies to hepatitis C virus in Ethiopia. Am J Trop Med Hyg 19[r]

Int. J. Med. Sci. 2006, 3 75International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(2):75-78 ©2006 Ivyspring International Publisher. All rights reserved Review Antiviral therapy of HCV in the cirrhotic and transplant candidate Steven K. Herrine, and Victor J. Navarro Divisio[r]

non-responders to peginterferon alpha 2b and ribavirin. In: AASLD (Abstract 413); Oct 29- Nov 2 2004; Boston, MA. 36. Gross JB et al. Renew Trial- High dose re-treatment with peginterferon alpha 2b plus ribavirin for non responders in chronic HCV patients. In: AASLD 2003 (Abstract 321); Oct 24-28 20[r]

n 342 219 211 8 chd present 81 71 70 1 0.033 BMI (kg/m²) 22.1±1.5 22.9±1.3 22.9±1.1 23.1±1.1 0.023 Cholesterol (mg/dl) 270.5±51.2 266.2±89.4 266.4±93.2 262±64.5 ns LDL 183±46.8 189±54.8 194±53.9 174.6±62.5 ns HDL 65.5±20.6 53.5±16 54±16 58.2±17.8 0.004 VLDL 22±13.2 23±8.8 23.4±8.8 19.2±4.8 ns Trigly[r]

18. Farci P, et al. Hepatitis C virus-associated fulminant hepatic failure. N Engl J Med, 1996. 335(9): 631-4. 19. Vogt M, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med, 1999.[r]

Int. J. Med. Sci. 2006, 3 79International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(2):79-83 ©2006 Ivyspring International Publisher. All rights reserved Review Management of HCV Infection and Liver Transplantation Thomas D. Schiano, and Paul Martin Adult Liver Transplantation[r]

Int. J. Med. Sci. 2006, 3 75International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(2):75-78 ©2006 Ivyspring International Publisher. All rights reserved Review Antiviral therapy of HCV in the cirrhotic and transplant candidate Steven K. Herrine, and Victor J. Navarro Divisio[r]

histopathological aspects. J Gastroenterology Hepatic, 1991. 6: 125-130. 5. Marshall BJ., Armstrong JA., and McGechie DB. Attempt to fulfill Koch’s postulate for pyloric Campylobacter. Med J Aust, 1985. 142: 436-439. 6. Sipponen P. Gastric cancer — a long-term consequence of Helicobacter pylo[r]

Int. J. Med. Sci. 2006, 3 79International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2006 3(2):79-83 ©2006 Ivyspring International Publisher. All rights reserved Review Management of HCV Infection and Liver Transplantation Thomas D. Schiano, and Paul Martin Adult Liver Transplantation[r]

and peripheral blood (PB) samples from 13 Patients with AML were obtained at the time of their initial diagnosis after informed consent. For control, 51 PB samples were obtained from voluntary healthy individuals after informed consent. Mononuclear cells were separated by density gradient centrifuga[r]

6. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004; 65(4):1416–1421. 7. Shimizu-Tokiwa A, Kobata M, Io H, Kobayashi N, Shou I, Funa[r]

association between maternal use of loratadine in early pregnancy and birth of infants with hypospadias was the result of multiple testing. Acknowledgments The study was supported by a grant from K A Wallenberg Foundation, Sweden, to BK. Conflict of interest The authors have declared that no conflic[r]

A group of 16 females, aged 80-93 years old, was divided into 2 groups according to their baseline DHEA-S lev-els: Lower Halves (N = 8) and Upper Halves (N = 8), and participated in a 4-month exercise intervention trial. Insulin response with an oral glucose tolerance test (OGTT), cholesterol[r]

Int. J. Med. Sci. 2007, 4 83International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2007 4(2):83-93 © Ivyspring International Publisher. All rights reserved Review Rasburicase represents a new tool for hyperuricemia in tumor lysis syn-drome and in gout Lisa Cammalleri and Mariano Ma[r]

4. Hadziyannis SJ, Sette HJr., Morgan TR, Balan V, Diago M, et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004; 140: 346-55. 5. Muir AJ, Bornstein JD and Killenberg PG. Peginterferon[r]

among natural weight loss supplements. Theoretically, they may promote weight loss by interfering with the breakdown of complex carbohydrates thereby reducing, or at least slowing, the digestive availability of carbo-hydrate-derived calories and/or by providing resistant starches to the lower gastro[r]